| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 571 |
| 1 | OLANZAPINE | 551 |
| 2 | RISPERIDONE | 545 |
| 3 | QUETIAPINE | 535 |
| 4 | OLANZAPINE PAMOATE | 501 |
| 5 | CLOZAPINE | 432 |
| 6 | LURASIDONE HYDROCHLORIDE | 431 |
| 7 | QUETIAPINE FUMARATE | 427 |
| 8 | ARIPIPRAZOLE ORAL | 423 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 423 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE HCL | 370 | 0.1391 |
| 1 | ASENAPINE MALEATE | 415 | 0.0479 |
| 2 | ZIPRASIDONE | 115 | 0.0319 |
| 3 | FLUPHENAZINE DECANOATE | 12 | 0.0276 |
| 4 | LURASIDONE HYDROCHLORIDE | 431 | 0.0206 |
| 5 | OLANZAPINE PAMOATE | 501 | 0.0123 |
| 6 | PALIPERIDONE PALMITATE | 292 | 0.0089 |
| 7 | OLANZAPINE | 551 | 0.0079 |
| 8 | RISPERIDONE | 545 | 0.0072 |
| 9 | ZIPRASIDONE MESYLATE | 94 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 692 |
| 1 | Typical Antipsychotic [EPC] | 36 |
| 2 | Benzodiazepine [EPC] | 30 |
| 3 | Mood Stabilizer [EPC] | 29 |
| 4 | Anti-epileptic Agent [EPC] | 28 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 6 | Serotonin Reuptake Inhibitor [EPC] | 8 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 |
| 8 | Anticholinergic [EPC] | 5 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 692 | 0.0015 |
| 1 | Typical Antipsychotic [EPC] | 36 | 0.0014 |
| 2 | Ergot Derivative [EPC] | 4 | 0.0008 |
| 3 | Anticholinergic [EPC] | 5 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Melatonin Receptor Agonist [EPC] | 2 | 0.0002 |
| 6 | Mood Stabilizer [EPC] | 29 | 0.0001 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 5 | 0.0001 |
| 9 | Anti-epileptic Agent [EPC] | 28 | 0.0001 |